Home - Gastroenterology Advisor
While HIPAA rules protect health information of patients in hospitals and for physician visits, generally they do not protect the privacy or security of a patient’s health and wellness information when it is created accessed through or stored on personal cell …
Clinician Insights on How to Manage Semaglutide-Induced …
2023年9月8日 · Patients who receive treatment with a glucagon-like peptide-1 (GLP-1) receptor agonist, such as semaglutide, may experience delayed gastric emptying due to the drug’s mechanism of action (MOA). 1 Symptoms may include nausea, vomiting, heartburn, pain, or bloating. 2 However, the symptoms of delayed gastric emptying resulting from GLP-1 receptor agonists may be similar to symptoms of ...
What We Know About Semaglutide Adverse Events and …
2023年9月1日 · What Are Other Causes of Gastroparesis? Diabetes is the most common underlying cause of gastroparesis and can damage the vagus nerve, leading to impaired muscular function in the stomach and small intestine. 3 Studies show that the 10-year cumulative incidence of diabetic gastroparesis is estimated to be 5.2% among patients with type 1 diabetes and 1% in patients with type 2 diabetes. 4
Gastroparesis Awareness Month: Updated Guidelines to Treat …
2022年8月19日 · The American College of Gastroenterology (ACG) released updated clinical guidelines on managing gastroparesis (GP). The new recommendations were published in The American Journal of Gastroenterology.. GP is characterized by delayed gastric emptying (GE) of solid food in the absence of mechanical obstruction.
Bariatric Surgery for Weight Loss: Gastric Sleeve vs Gastric Bypass
2024年11月1日 · References: Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): indications for metabolic and bariatric surgery. Surg Obes Relat Dis. 2022;18(12):1345-1356. doi: 10.1016/j.soard.2022.08.013 American Society for Metabolic and Bariatric Surgery.
News and Features - Gastroenterology Advisor
While HIPAA rules protect health information of patients in hospitals and for physician visits, generally they do not protect the privacy or security of a patient’s health and wellness information when it is created accessed through or stored on personal cell …
FDA Alert: Gastroenterology Drug Approvals and New Indications
2024年9月27日 · Over the summer, the US Food and Drug Administration (FDA) approved a biosimilar for Crohn disease (CD) and ulcerative colitis (UC), a blood-based test for colorectal cancer (CRC) screening, a new indication for heartburn associated with nonerosive gastroesophageal reflux disease (GERD), a new indication for UC, and a new indication for younger patients with progressive familial intrahepatic ...
Upper GI Tract Disorders Treated With P-CABs: AGA Clinical …
2024年10月25日 · The American Gastroenterological Association (AGA) has released a clinical practice update for managing upper gastrointestinal (GI) tract disorders with potassium-competitive acid blockers (P-CABs).
Chronic Idiopathic Constipation: 10 Recommendations for …
2023年6月9日 · The American Gastroenterological Association (AGA) and the American College of Gastroenterology (ACG) have jointly developed a clinical practice guideline regarding the pharmacological management of patients with chronic idiopathic constipation (CIC), as published in the American Journal of Gastroenterology and Gastroenterology.. The guideline provides 10 evidence-based recommendations for ...
Intestinal Ultrasound for IBD: Clinical Practice Update From the AGA
2024年8月2日 · The American Gastroenterological Association (AGA) released a clinical practice update in Clinical Gastroenterology and Hepatology about the role of intestinal ultrasound (IUS) in the management of inflammatory bowel diseases (IBDs).. The primary objectives in IBD management are to reverse endoscopically evident inflammation, maintain long-term remission, and to avoid complications.